机构名称：
¥ 1.0
Yet we've seen enormous strides in our understanding and treatment of MS, including: • The licensing of two disease modifying therapies (DMTs) for progressive MS, and huge expansion of the progressive MS clinical trial landscape • New mechanisms of progression identified, and the concept of treating ‘progression independent of relapses' gaining traction • Progress in predicting MS prognosis with advanced MRI techniques • As DMTs are lengthening生命周期，更需要临床关注症状，健康，生活质量以及管理多种物质的重要性•研究社区产生的动量围绕防止MS产生的动量，并突破性论文关于爱泼斯坦Barr Virus（EBV）的潜在因果作用的突破性论文。•增加公共和患者参与的概况（PPI）•平等，多样性和包容（EDI）成为国家优先事项•在组织和条件之间增加资金合作文化•扩大了MS Research
研究策略2023-24扩展
主要关键词
相关文件推荐
